Postprandial hypoglycaemia – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:32:40 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Postprandial hypoglycaemia – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effects of Pasireotide in Patients with Low Blood Sugar After Bariatric Surgery https://clinicaltrials.eu/trial/study-on-the-effects-of-pasireotide-in-patients-with-low-blood-sugar-after-bariatric-surgery/ Wed, 29 Apr 2026 14:29:30 +0000 https://clinicaltrials.eu/trial/study-on-the-effects-of-pasireotide-in-patients-with-low-blood-sugar-after-bariatric-surgery/ This clinical trial is focused on studying a condition known as Post-Bariatric Hypoglycemia (PBH), which can occur in some individuals after they have undergone weight-loss surgery. This condition is characterized by low blood sugar levels after eating, which can lead to symptoms like dizziness, confusion, and even fainting. The study is testing a treatment called Pasireotide Diaspartate, which is a type of medication that mimics a natural hormone in the body to help control blood sugar levels. The medication is given as a solution for injection under the skin.

The purpose of the study is to evaluate how effective and safe Pasireotide Diaspartate is in managing blood sugar levels in patients with PBH. Participants in the study will receive either the medication or a placebo, which is an inactive substance, to compare the effects. The study will last for a period of 12 weeks, during which participants will be monitored for changes in their blood sugar levels and any side effects they may experience. The study aims to find the most effective dose of the medication that can help manage the symptoms of PBH.

Throughout the study, participants will undergo regular assessments to track their blood sugar levels and overall health. These assessments will help researchers understand how Pasireotide Diaspartate affects the body and its potential benefits for people with Post-Bariatric Hypoglycemia. The study is designed to provide valuable information that could lead to better treatment options for individuals experiencing this condition after bariatric surgery.

]]>